Smith Douglas Homes Corp. (SDHC) stock: key figures, P/E, revenue and dividend
Industrials · United States · ISIN US83207R1077
Smith Douglas Homes Corp. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 971.12 m USD |
| Gross profit | 212.17 m USD |
| EBIT | 74.10 m USD |
| Net income | 10.69 m USD |
| Diluted EPS – continuing operations | 1.19 USD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Smith Douglas Homes Corp.
Smith Douglas Homes Corp. is headquartered in Woodstock, Georgia, Smith Douglas Homes completed its initial public offering in January 2024. Since its inception, Smith Douglas has been entrusted by over 20,000 families to fulfill their new home dreams. Ranked a top 50 builder nationally for several years and with 2,908 closings in 2025, Smith Douglas currently holds the #32 position on the Builder Magazine Top 100 list. The Smith Douglas communities are primarily targeted to entry-level and empty-nest homebuyers looking to purchase a new home priced below the Federal Housing Administration loan limit in the metro areas of Atlanta, Birmingham, Central Georgia, Charlotte, Chattanooga, Dallas-Fort Worth, Greenville, Houston, Huntsville, Nashville, Raleigh, and the Alabama Gulf Coast. Smith Douglas offers its homebuyers a personalized, affordable buying experience at attractive prices, delivering exceptional value and quality. Smith Douglas Homes Corp. was incorporated in Delaware, USA.
More stocks
- Tamawood Ltd (TWD.AX)
- HLS Therapeutics Inc (HLS.TO)
- InsCorp Inc (IBTN)
- Genic Co. Ltd (123330.KQ)
- Lee Ku Ind (025820.KS)
- Empress Royalty Corp (EMPR.V)
- Dual Co Ltd (016740.KS)
- Klingon Aerospace Inc (1529.TW)
- Feature Integration Technology Inc. (4951.TWO)
- Life Travel & Tourist Service Co., Ltd. (2745.TWO)
- DY Power Corp (210540.KS)
- Coherus Oncology, Inc. (CHRS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.